Kanada - Inggeris - Health Canada

teva canada limited - diclofenac sodium - tablet (enteric-coated) - 25mg - diclofenac sodium 25mg - other nonsteroidal antiimflammatory agents

Kanada - Inggeris - Health Canada

teva canada limited - diclofenac sodium - tablet (enteric-coated) - 50mg - diclofenac sodium 50mg - other nonsteroidal antiimflammatory agents

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

rising pharma holdings, inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 75 mg - carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac sodium delayed-release tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings: gastrointestinal bleeding, ulceration and perforation ). diclofenac sodium delayed-release tablets are indicated: - for relief of the signs and symptoms of osteoarthritis - for relief of the signs and symptoms of rheumatoid arthritis - for acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis diclofenac sodium delayed-release tablets are contraindicated in the following patients. - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac or any components of the drug product (see warnings: anaphylactic reactions , serious skin reactions ). - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other n

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

soul pattinson manufacturing pty ltd - diclofenac sodium, quantity: 25 mg - tablet, enteric coated - excipient ingredients: triethyl citrate; microcrystalline cellulose; titanium dioxide; colloidal anhydrous silica; hypromellose; magnesium stearate; povidone; lactose monohydrate; iron oxide yellow; purified talc; purified water; maize starch; peg-40 hydrogenated castor oil; sodium starch glycollate type a; polysorbate 80; methacrylic acid copolymer; sodium lauryl sulfate - relief of acute pain states in which there is an inflammatory component.,symptomatic treatment of primary dysmenorrhoea.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

symbion pty ltd - diclofenac sodium, quantity: 25 mg - tablet, enteric coated - excipient ingredients: iron oxide yellow; hypromellose; purified talc; microcrystalline cellulose; lactose monohydrate; colloidal anhydrous silica; magnesium stearate; povidone; titanium dioxide; maize starch; purified water; sodium starch glycollate type a; peg-40 hydrogenated castor oil; triethyl citrate; polysorbate 80; methacrylic acid copolymer; sodium lauryl sulfate - relief of acute pain states in which there is an inflammatory component.,symptomatic treatment of primary dysmenorrhoea.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - diclofenac sodium, quantity: 50 mg - tablet, enteric coated - excipient ingredients: lactose monohydrate; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; maize starch; sodium starch glycollate; magnesium stearate; colloidal anhydrous silica; methacrylic acid copolymer; triethyl citrate; purified talc; titanium dioxide; iron oxide yellow - inflammatory and degenerative forms of rheumatism; rheumatoid arthritis; osteoarthritis. relief of acute or chronic pain states in which there is an inflammatory component. symptomatic treatment of primary dysmenorrhoea

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - diclofenac sodium, quantity: 25 mg - tablet, enteric coated - excipient ingredients: lactose monohydrate; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; maize starch; sodium starch glycollate; magnesium stearate; colloidal anhydrous silica; methacrylic acid copolymer; triethyl citrate; purified talc; titanium dioxide; iron oxide yellow - inflammatory and degenerative forms of rheumatism; rheumatoid arthritis; osteoarthritis. relief of acute or chronic pain states in which there is an inflammatory component. symptomatic treatment of primary dysmenorrhoea

Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - diclofenac potassium - film coated tablet - 50 milligram - acetic acid derivatives and related substances

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - diclofenac sodium, quantity: 25 mg - tablet, enteric coated - excipient ingredients: sodium starch glycollate type a; iron oxide yellow; povidone; methacrylic acid - ethyl acrylate copolymer (1:1); maize starch; microcrystalline cellulose; titanium dioxide; purified talc; magnesium stearate; hypromellose; lactose monohydrate; triethyl citrate; peg-40 hydrogenated castor oil; colloidal anhydrous silica - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. relief of acute or chronic pain states in which there is an,inflammatory component. symptomatic treatment of primary dysmenorrhoea.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - diclofenac sodium, quantity: 50 mg - tablet, enteric coated - excipient ingredients: lactose monohydrate; purified talc; povidone; microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide; iron oxide red; hypromellose; methacrylic acid - ethyl acrylate copolymer (1:1); triethyl citrate; sodium starch glycollate type a; maize starch; peg-40 hydrogenated castor oil; magnesium stearate; iron oxide yellow - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. relief of acute or chronic pain states in which there is an,inflammatory component. symptomatic treatment of primary dysmenorrhoea.